trial

Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)

NCTId NCT00229385
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 45 (actual)
Sponsored by Sheba Medical Center
Primary completion 2008-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
45 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
Single
Start
2006-01
Primary completion
2008-04
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Ziprasidone

Sponsors

Sheba Medical CenterLead Sponsor

Investigators

1
Joseph Zohar, MDPrincipal Investigator

Sites

1 total
Ramat Gan, Israel

Facts & assertions

4 sourced
Enrollment
45
Phase
NA
Primary Completion Date
2008-04
Status
COMPLETED
relationships
The graph out of here
drug
Ziprasidone
drug
lead_sponsor
Sheba Medical Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
Obsessive Compulsive Disorder
indication
investigator
Joseph Zohar, MD
person